Nurse-Administered Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Two-Year Follow-Up StudyShow others and affiliations
2025 (English)In: United European Gastroenterology journal, ISSN 2050-6406, E-ISSN 2050-6414, Vol. 13, no 7, p. 1307-1317Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Gut-directed hypnotherapy is effective for irritable bowel syndrome (IBS) and a few studies have reported long-lasting therapeutic effects following intervention. No previous studies have evaluated the long-term effects of nurse-administered hypnotherapy.
AIMS: We aimed to investigate the long-term effects of nurse-administered gut-directed hypnotherapy for IBS and identify factors associated with symptom improvement. Furthermore, we aimed to compare treatment effects between individual and group hypnotherapy.
METHODS: A 2-year follow-up study including 289 patients with IBS who had completed a 12-week hypnotherapy program (individually or in groups) was conducted. Data were collected at baseline, and at 6-month-, 1-year- and 2-year follow-ups. Irritable bowel syndrome and extracolonic symptom severity (IBS-SSS), gastrointestinal-specific anxiety (VSI), and anxiety and depressive symptoms (HADS) were assessed. Patients reporting a reduction ≥ 50 points (IBS-SSS) were classified as treatment responders.
RESULTS: The 2-year follow-up was completed by 207 patients. The proportion of responders at post-treatment was 64.3%, 62.8% at the 6-month follow-up, 64.7% at the 1-year follow-up, and 61.8% at the 2-year follow-up. The severity of IBS symptoms, extracolonic and psychological symptoms were all reduced post-treatment, and this effect lasted over the 2-year follow-up period (p < 0.001). Younger age, individual hypnotherapy, and severe irritable bowel syndrome symptoms at baseline predicted a better response to treatment (R2 = 0.16).
CONCLUSIONS: Nurse-administered gut-directed hypnotherapy is an effective treatment for IBS with long-lasting symptom improvements. Younger age, severe irritable bowel syndrome symptoms, and individual treatment might be important factors associated with effectiveness (ClinicalTrials.gov study protocol IDs: NCT06167018, NCT03432078).
TRIAL REGISTRATION: ClinicalTrials.gov study protocol IDs: NCT06167018, NCT03432078.
Place, publisher, year, edition, pages
John Wiley & Sons, 2025. Vol. 13, no 7, p. 1307-1317
Keywords [en]
Extracolonic symptom, gut‐brain axis, hypnotherapy, irritable bowel syndrome, nurse, psychological treatment
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-121563DOI: 10.1002/ueg2.70060ISI: 001506055000001PubMedID: 40491242Scopus ID: 2-s2.0-105007533954OAI: oai:DiVA.org:oru-121563DiVA, id: diva2:1968829
Funder
Region Västra Götaland, VGFOUREG 855971Region Västra Götaland, VGFOUREG 930214Swedish Research Council, 2018-02566Swedish Research Council, 2021-00947University of Gothenburg
Note
Funding Agencies:
This study was funded by the Healthcare Committee, Region Västra Götaland (Grants VGFOUREG 855971 and VGFOUREG 930214), the Swedish Research Council (Grants 2018-02566 and 2021-00947), the ALF- agreement (Grants ALFGBG-726561, ALFGBG-965173, ALFGBG-722331 and ALFGBG-983998) and the Faculty of Medicine, University of Gothenburg.
2025-06-132025-06-132026-01-09Bibliographically approved